Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Concord Medical Technology is a leading oncology healthcare provider in China and a primary operating subsidiary of the NYSE-listed Concord Medical Services Holdings Limited. The company specializes in the operation of a vast network of radiotherapy and diagnostic imaging centers through long-term partnerships with hospitals across the country. In addition to its network operations, it develops and manages high-end specialty cancer hospitals and provides advanced medical equipment, including proton therapy systems. Through a strategic collaboration with MD Anderson Cancer Center, the company integrates international clinical standards into its oncology services to improve cancer care outcomes in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Concord Medical Technology.